Ad is loading...
ALLR
Price
$1.10
Change
+$0.02 (+1.85%)
Updated
Dec 6 closing price
NCNA
Price
$1.33
Change
+$0.11 (+9.02%)
Updated
Dec 6, 04:59 PM (EDT)
Ad is loading...

ALLR vs NCNA

Header iconALLR vs NCNA Comparison
Open Charts ALLR vs NCNABanner chart's image
Allarity Therapeutics
Price$1.10
Change+$0.02 (+1.85%)
Volume$139.16K
CapitalizationN/A
NuCana
Price$1.33
Change+$0.11 (+9.02%)
Volume$496
CapitalizationN/A
ALLR vs NCNA Comparison Chart
Loading...
ALLR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NCNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ALLR vs. NCNA commentary
Dec 09, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLR is a Sell and NCNA is a Buy.

COMPARISON
Comparison
Dec 09, 2024
Stock price -- (ALLR: $1.10 vs. NCNA: $1.34)
Brand notoriety: ALLR and NCNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLR: 33% vs. NCNA: 82%
Market capitalization -- ALLR: $4.79M vs. NCNA: $4.87M
ALLR [@Biotechnology] is valued at $4.79M. NCNA’s [@Biotechnology] market capitalization is $4.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $489.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLR’s FA Score shows that 1 FA rating(s) are green whileNCNA’s FA Score has 1 green FA rating(s).

  • ALLR’s FA Score: 1 green, 4 red.
  • NCNA’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALLR and NCNA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLR’s TA Score shows that 4 TA indicator(s) are bullish while NCNA’s TA Score has 5 bullish TA indicator(s).

  • ALLR’s TA Score: 4 bullish, 3 bearish.
  • NCNA’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, NCNA is a better buy in the short-term than ALLR.

Price Growth

ALLR (@Biotechnology) experienced а 0.00% price change this week, while NCNA (@Biotechnology) price change was +3.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -2.68%, and the average quarterly price growth was +10.76%.

Reported Earning Dates

ALLR is expected to report earnings on May 15, 2023.

NCNA is expected to report earnings on Aug 14, 2024.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NCNA($4.87M) and ALLR($4.79M) have the same market capitalization . NCNA YTD gains are higher at: -81.880 vs. ALLR (-99.667). ALLR has higher annual earnings (EBITDA): -18.26M vs. NCNA (-33.04M). ALLR has more cash in the bank: 18.5M vs. NCNA (11.6M). NCNA has less debt than ALLR: NCNA (281K) vs ALLR (1.34M). ALLR (0) and NCNA (0) have equivalent revenues.
ALLRNCNAALLR / NCNA
Capitalization4.79M4.87M98%
EBITDA-18.26M-33.04M55%
Gain YTD-99.667-81.880122%
P/E RatioN/AN/A-
Revenue00-
Total Cash18.5M11.6M159%
Total Debt1.34M281K476%
FUNDAMENTALS RATINGS
NCNA: Fundamental Ratings
NCNA
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
46

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLRNCNA
RSI
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 14 days ago
78%
Bullish Trend 13 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
81%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Ad is loading...
ALLR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NCNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLMD2.800.24
+9.38%
Galmed Pharmaceuticals Ltd
DDD2.900.20
+7.41%
3D Systems Corp
EPSN5.830.20
+3.55%
Epsilon Energy Ltd
FMS24.06-0.12
-0.50%
Fresenius Medical Care AG
SID1.83-0.05
-2.66%
Companhia Siderurgica Nacional SA

ALLR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLR has been closely correlated with SNPX. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if ALLR jumps, then SNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLR
1D Price
Change %
ALLR100%
+1.85%
SNPX - ALLR
87%
Closely correlated
-4.05%
AGEN - ALLR
87%
Closely correlated
+14.01%
RNAC - ALLR
86%
Closely correlated
+9.26%
NCNA - ALLR
86%
Closely correlated
+9.84%
NRXP - ALLR
81%
Closely correlated
+2.52%
More

NCNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NCNA has been closely correlated with RNAC. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if NCNA jumps, then RNAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NCNA
1D Price
Change %
NCNA100%
+9.84%
RNAC - NCNA
93%
Closely correlated
+9.26%
AGEN - NCNA
93%
Closely correlated
+14.01%
SNPX - NCNA
92%
Closely correlated
-4.05%
ALLR - NCNA
86%
Closely correlated
+1.85%
NRXP - NCNA
85%
Closely correlated
+2.52%
More